BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed EPRX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:f5f001440c4843f09f6c@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:EPRX P1/P2 readout (est.): RESOLVE
DESCRIPTION:A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esopha
 gitis (EoE).\nNCT05608681 | PHASE1/PHASE2 | RECRUITING | sponsor: Eupraxia
  Pharmaceuticals Inc.\nPrimary completion date (ESTIMATED)\; top-line resu
 lts usually follow later.\nDate precision: month (shown on the first day)\
 nTicker EPRX (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NC
 T05608681\nScheduling/reference data from public records\; dates can move.
  Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05608681
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
